At the sametime, a clinical study showed that the combination therapy of statins(atorvastatin) and telmisartan (angiotensin II receptor blocker, ARB) reducedboth miR-146a/b-5p and Toll-like receptor 4 (TLR4) signaling in patients withcoronary artery disease. This evidence concerns the gene TLR4 and arterial disorder.